Biotechnology investments are reshaping the future of healthcare, agriculture, and sustainable industry. Featured.com's expert directory connects you with leading biotech investment strategists, venture capitalists, and industry analysts who have been featured in top-tier publications. These professionals offer invaluable insights on market trends, emerging technologies, and investment opportunities in this rapidly evolving sector. For publishers and media outlets, our platform provides instant access to authoritative voices for articles, interviews, and expert commentary on biotechnology funding and market dynamics. Biotech investment experts can leverage this directory to enhance their visibility and establish themselves as go-to sources in this cutting-edge field. Whether you're seeking expert analysis for your next biotech investment piece or looking to share your expertise with a wider audience, our directory is your gateway to impactful connections. Explore the profiles below to discover biotech investment experts who can provide the insights you need.
Connect directly with our network of vetted biotechnology investments experts for interviews, quotes, or in-depth analysis.
Many experts respond within hours to media requests
All experts undergo background and credential verification
No fees to connect with experts for legitimate media requests
Join our network of professionals and connect with journalists and publishers looking for your expertise.
Showing 20 of 750 experts
Co-Founder and CIIO at OXCCU
Started my career at Sagentia Innovation, I helped global consumer and industrial companies such as P&G to identify and evaluate market opportunities of new technologies and products. I joined Oxford University Innovation in 2016, focusing on commercialising Oxford University's research outcomes through licensing and creating spin-out ventures. I am passionate about cleantech innovation, currently leading a Climate Tech initiative at OUI, launched the Oxford Climate Tech and Sustainability Innovation Challenge 2021 this summer to engage Oxford researchers and local innovation eco-system to tackle climate crisis together. I am always eager and self-motivated to learn new knowledge and develop new skills, enjoying the challenges of stepping out of comfort zone while keeping the focus. I am passionate about innovation and entrepreneurship, and how to bring these together to create real impact to the society. I am a great team player, sociable and optimistic. I enjoy leading, coaching and mentoring, in particular when I can support and make others succeed in their endeavours
Featured In:
CBDO & Principal at Digital Ascension Group
Max Avery, a dynamic business development executive at Digital Ascension Group, drives growth across industries with a sharp focus on market leadership. His deep knowledge of traditional and emerging financial markets, backed by certifications like Capital Markets & Securities Analyst (CMSA)® and FinTech Industry Professional (FTIP)™, informs his strategic approach. Since 2016, he has excelled in raising capital and structuring deals in private equity and real estate. Appointed to the District Export Council by Secretary of Commerce Wilbur Ross in 2018, and a member of the National Small Business Association’s Economic Development Committee, Avery shapes policies for business growth. Guided by a philosophy of excellence, he turns complex challenges into practical solutions, establishing himself as a trusted strategist committed to lasting impact.
Featured In:
Scientist, Biohacker, Transhumanist, AI Engineer at Syndicate Laboratories
Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.
Featured In:
Founder at Finance Ideas
I am a U.S.-focused finance professional with over 10 years of experience in investment analysis, personal finance strategy, and accounting. I founded FinanceIdeas.org, where I publish real-world guides that help individuals and families solve complex financial problems; from retirement anxiety to market panic. My background blends academia, corporate finance, and consulting. I have served as a lecturer in accounting and as a financial analyst supporting strategic decisions in the investment sector. Today, I share my research-backed financial strategies in global media outlets and academic platforms like SSRN and ResearchGate. I specialize in topics such as investment psychology, risk-adjusted portfolio strategies, crypto investing, and behavior-driven financial planning. My goal is to translate timeless financial wisdom into actionable steps anyone can use to build long-term wealth. Need expert insights on crypto, investing, Accounting or financial panic-proofing? Contact me via FinanceIdeas.org or just e-mail me directly at kumartaposbanarjee@gmail.com
Featured In:
CEO and Founder at Extract Labs
I'm the CEO and founder of Extract Labs, a Boulder, Colorado-based full-service hemp extraction laboratory offering a proprietary line of boutique CBD-infused products. I started the company out of my garage in 2016. Prior to founding Extract Labs, I was the Senior Sales Engineer for Apeks Supercritical, based out of Denver Colorado. I performed technical sales, and managed all national and international training and service on Apeks extraction systems. I also performed cannabis related research and development, and taught classes specifically on advanced CO2 extraction techniques along with pre and post processing techniques. I received both a Bachelor and Master of Science degree in Mechanical Engineering from the University of Louisville with a concentration in thermal sciences and renewable energy. Prior to my undergraduate and graduate studies, I served as an infantryman and Team Leader in the US Army during Operation Iraqi Freedom from 2002 to 2006.
Featured In:
Co-Founder at Mitigata: Smart Cyber Insurance
Co-Founder, Mitigata Insurance, Tao.liveBuilt Products for Delhivery, Lenskart, Novopay earlierB.Tech. MIT Manipalhttps://twitter.com/Sarthakdubey
Featured In:
Co-Founder at Black Seed Ink
Robin Hillary — President & Co-Founder, Black Seed Ink | CEO, LitCentral Robin Hillary is a U.S. design-patent holder and certified in Blockchain & Cryptocurrency (UC Berkeley) and AI for Leaders (Babson College). As President and Co-Founder of Black Seed Ink, she leads the only cold-storage company in the world offering a full stack of backup solutions for self-custody investors—not just seed-phrase plates, but passphrase, exchange-login, and master-password plates, plus index notebooks, cases, and protective capsules. Trusted by crypto whales and everyday holders in 85+ countries and territories, Black Seed Ink’s fire-rated steel wallets have earned top marks in independent stress tests (e.g., Jameson Lopp’s), and serve thousands of customers who want their keys - and anything worth remembering - kept offline. Previously, as Chief Innovation Officer at Credit.org, Robin built tech-anchored programs in credit, debt, and housing counseling, launched the nonprofit Reverse Mortgage Academy, and created LenderView - the first platform that gives lenders a real-time window into outcomes from pre-purchase and mortgage-readiness counseling, closing the data gap between advisors and underwriters. Now as CEO of LitCentral, Robin is developing AI-driven tools that connect physical and financial health for employers. Fueled by espresso and an innovation mindset, she marries hands-on hardware design with practical fintech that protects people and powers confidence. Quotes "We design crypto cold storage for the day everything goes wrong." - Robin Hillary “I build tools that protect what you can’t afford to forget.” - Robin Hillary “On-chain finance is a web of rails moving art, deeds, money, and RWAs like gold and real estate. If you’re climbing aboard, start with security - lock down your keys in steel and hold on for dear life!" - Robin Hillary
Featured In:
Chief Investment Officer at NKD Advisory, LLC
Neil Datta is a seasoned investment professional with over two decades of experience across family offices, hedge funds, private equity, venture capital, and institutional asset management. As Founder and Managing Partner of NKD Advisory, he advises ultra-high-net-worth families, sovereign investors, and entrepreneurs on how to navigate alternatives while also launching innovative private credit and multi-asset strategies. Over his career, Neil has personally reviewed 2,000 fund managers globally—giving him one of the most comprehensive perspectives in the industry. His expertise bridges institutional rigor with the personalized needs of family offices, making him a trusted voice on how wealth is created, preserved, and transitioned across generations. Family Offices & UHNW: Neil speaks frequently about intergenerational dynamics, governance, and how younger heirs are driving new allocations into venture, technology, and impact investing. He also highlights the lifestyle dimensions of wealth, from philanthropy and passion investing to structuring real estate, art, and sports holdings. Hedge Funds & Portfolio Management: With deep experience allocating to hedge funds, Neil offers insight into liquidity vs. performance trade-offs, the rise of multi-strategy firms, and the behavioral discipline required for long-term success. He emphasizes portfolio construction around risk exposures rather than rigid asset classes, backed by stress testing and scenario analysis. Venture Capital & Private Equity: Having founded a venture-backed fintech platform that raised $2M from institutional investors, Neil brings founder empathy to venture discussions. He comments on GP/LP dynamics, the boom in co-investments, and opportunities across fintech, healthcare, consumer, and sports/media. Institutional Asset Management: Early experience at Salomon Smith Barney shaped Neil’s institutional lens—governance, diversification, and balancing beta vs. alpha. He applies these lessons for family offices without the bureaucratic inertia of large institutions. Neil is known as a connector of people, capital, and ideas. His global network spans top hedge funds, private equity firms, and next-generation wealth leaders, and his perspectives are sought by media for their clarity and accessibility. He combines technical authority with the human dimension of wealth, offering not just financial insights but also a narrative of how money, meaning, and modernity intersect in today’s economy.
Business Development and Strategy Manager at OHMX.bio
Joannes van Cann is a talented manager with a unique blend of scientific and business acumen. He holds a PhD in molecular biology and is currently pursuing an MBA at an internationally renowned business school. With versatile experience across several European countries, Joannes has successfully progressed clinical trials of world-class clients. Furthermore, he has assisted in the Strategic Corporate Development of his employer, by performing various Business Analyses and contributing to the overall strategy. Joannes is seeking a challenging role that demands a strategic business insight and offers a measurable impact on a company, business unit or team. As a skilled communicator, leader, and strategist, he excels in using his skills to the company’s advantage. He has shown to be flexible, adaptive, problem-solving, stress-resilient and creative. His commitment to lifelong learning and professional development makes him an asset to any organization.
CEO at Paradigm Asset Management
Visionary and Entrepreneurial leader that delivers a unique combination of strategic, operational, technical, and transactional expertise in finance, media and tech.
Featured In:
Tech Entrepreneur & Biohacker
Abe Issa was founder of Envirosolar which was the 2nd fastest growing private company in the U.S. in 2017 according to INC Magazine and has been a top solar company nationally in terms of originations. Abe Issa was honored to have Envirosolar recognized by Stevie Awards, Solar Power Magazine, and has been mentioned in the national media for its efforts in the ever growing solar industry. As a national employer , Abe Issa is passionate about job creation and supporting our communities. Envirosolar was also the first national company that integrated solar & smart home into one platform. Abe Issa is also involved in several non-profits throughout the country.Abe Issa was one of the first entrepreneurs to do residential energy efficiency and solar in the south. He built numerous sales platforms and systems that have helped scale the top companies in the industry. Through his sales efforts, Abe Issa has created thousands of jobs throughout the country in the solar industry.
Featured In:
CEO at Coastal Kapital LLC
Coastal Kapital LLC is a financial services leader in commercial equipment financing and working capital. We maintain thousands of relationships with business owners, vendors, and manufacturers across the US who value partnerships as well as integrity. Our products at Coastal Kapital LLC include commercial equipment financing, working capital, merchant services, and business consulting. Coastal Kapital LLC was founded in 2007 under the original name Farhat Leasing LLC. Coastal Kapital LLC has also opened many doors for other successful account executives looking to further their careers. We are always looking for motivated individuals to help grow our business and expand their careers. Coastal Kapital LLC has relationships with over 20 funding sources to provide consultative relationships with long term solutions for each of our clients/partners.
Featured In:
Managing Director at FYNE IVF
Dr. Deepali Chinchole, MD in Obstetrics & Gynaecology, is a highly regarded IVF and Infertility Specialist based in Pune, bringing over 23 years of experience to her field. Known for her innovative approach and mastery of advanced technologies, she has successfully overseen more than 1000 IVF births. Dr. Chinchole currently serves as the Medical Director at Accord Hospitals and is a mentor at Fyne IVF.
Technology Recruitment Leader at Biotickr
Authentic technology recruitment leader with expertise in executive talent acquisition and building high performance recruitment teams, primarily within the tech/digital/creative disciplines.
Featured In:
CEO & Founder at GrowthFactor
I was born and raised in a retail family business, and I've seen firsthand how difficult it can be to find a great site for a store.I help retailers figure out where to put their next store.Evaluated 2,000+ sites for retail store expansion of top retail brands.
Featured In:
Chief Strategy Office at Market Access 360 Insights, Inc.
Skilled, highly knowledgeable, and analytical professional with over fourteen years experience in the healthcare sector. Primary expertise in providing strategic insights and actionable information to life science companies. Proficient in molecular diagnostics, point of care diagnostics, genomics, immunoassays, oncology diagnostics, cardiology diagnostics, infectious disease diagnostics and personalized medicine. Strong ability in capturing customer insights, performing technical analysis, sizing niche segments, financial modeling, evaluating market dynamics, identify/evaluate new product potential, and presenting high impact, tactical recommendations. Specialties: Extensive knowledge in the genomics, in-vitro diagnostics space. Demonstrated success in managing teams and clients, assessing business models identifying market opportunities/risks and developing strategies to optimize market penetration, competitive advantage and profit.
Featured In:
Founder and CEO at Alternative Wealth Partners
Over a decade of experience creating successful teams, exceeding sales goals, and developing effective marketing strategies for the private investment space. Through lead generation, networking, and various marketing tools, Kelly has helped raise over $500 million dollars of capital from individual private investors for several industries. She is an innovative problem solver and a natural leader focused on the big picture.
Featured In:
International Patent & Trademark Attorney at Tech Corp International Strategist
Prity Khastgir is a prominent figure in the fields of intellectual property law, technology strategy, and business innovation. Her extensive career spans over 18 years, during which she has achieved significant milestones and contributed to various sectors, particularly in intellectual property rights (IPR) and technology. Education and Training: - Selected for the Goldman Sachs 10,000 Women Executive Business Education Program, receiving a full scholarship from the Indian School of Business. This program is designed to empower women entrepreneurs with business education and leadership skills. - Founder and CEO of Tech Corp International Strategist (TCIS): Prity established TCIS to provide consultancy in intellectual property and technology strategy, catering to clients globally. - Patent Trainer at WIPO (World Intellectual Property Organization): She has been actively involved in training sessions that enhance understanding of patent laws and processes internationally. - Contributor and Journalist: Previously contributed to the China Economic Information Service, where she shares insights on technology and patents. Speaking Engagements - Recognized as an international speaker, Prity frequently addresses global conferences on the intersection of technology, law, and business within the context of Industry 4.0. She participates in ITU Regulatory Workshops focusing on Sustainable Development Goals (SDGs) and cybersecurity initiatives. Legal Expertise A registered patent attorney in India, Prity specializes in various aspects of intellectual property law, including patent drafting, prosecution, and managing complex IP portfolios for multinational corporations. Her expertise extends to sectors like pharmaceuticals, biotechnology, and telecommunications. Publications and Media Presence Featured in reputable publications such as BBC World, Nature Reviews Drug Discovery, and BioSpectrum Asia, highlighting her contributions to discussions on patents and technology. Prity Khastgir's career reflects a blend of legal acumen, technological insight, and a commitment to empowering others through education and strategic guidance in the rapidly evolving landscape of intellectual property rights.
Featured In:
Co-Founder at Uncle Tex Buys Houses
Patrick Schultz brings a sharp analytical edge to real estate investing, shaped by his experience as a research analyst for Jim Cramer on CNBC’s Mad Money. His deep understanding of financial markets, asset valuation, and investment strategies allows him to identify undervalued properties and optimize yield across his real estate portfolio. Alongside his wife, Hilary Schultz—a licensed real estate agent in Texas and Florida— their small family owned portfolio of businesses operate across every stage of residential real estate. They acquire homes, execute strategic renovations in SFR properties, and selectively retain assets that align with their long-term investment strategy. For Patrick and Hilary, real estate isn’t just about buying and selling—it’s about crafting solutions for homeowners. Whether purchasing homes for cash, revitalizing physically distressed properties, or helping sellers move forward with confidence, they approach every transaction with a problem-solving mindset. Their goal? Delivering outsized returns for investors while creating a delightful real estate experience for Texas home sellers.
Featured In:
CEO at Geisel Software
Brian Geisel is the visionary CEO of Geisel Software, a trailblazer in custom software solutions for robotics, automation, and AI/ML. With a deep technical background and a passion for innovation, Brian founded Geisel Software to create transformative, high-impact technology solutions that address complex, real-world challenges. Under his leadership, Geisel Software has become a premier provider of cutting-edge software for government agencies like NASA, Fortune 500 companies, and startups alike, with a strong focus on AI, machine learning, and high-stakes applications. With the launch of Symage, Brian has expanded Geisel’s impact in AI, introducing a powerful simulation platform that optimizes data collection and labeling for model training. Symage produces photorealistic, precisely labeled datasets, capitalizing on Geisel Software’s deep expertise in AI and machine learning. This approach is revolutionizing model training, enabling data scientists to accelerate their workflows while reducing both time and costs. Named SBA Small Business Person of the Year in 2020 and recognized on the Inc. 5000 list of fastest growing companies for four consecutive years, Brian is an influential voice in the AI and software development communities. His work exemplifies a commitment to forward-thinking technology and real-world applicability.
Featured In:
Showing 20 of 750 experts
When investing in biotechnology companies, key factors to consider include the company's pipeline of products in development, the potential market size for these products, the strength of their intellectual property portfolio, and their financial health. It's also crucial to assess the regulatory landscape, potential competitors, and the company's management team. Experts in this field can provide valuable insights into these factors, helping both journalists and investors navigate the complex and often volatile biotech investment landscape.
Biotech investment experts can significantly enhance financial journalism by providing in-depth analysis of market trends, explaining complex scientific breakthroughs and their potential market impact, and offering insights into the risks and opportunities within the biotechnology sector. Their expertise helps journalists create more accurate, detailed, and valuable content for readers, investors, and industry professionals, ultimately leading to better-informed decision-making in this rapidly evolving field.
Emerging trends in biotechnology that are likely to shape investment opportunities include advancements in gene therapy, the application of artificial intelligence in drug discovery, the development of personalized medicine, and innovations in biomanufacturing. Other promising areas include synthetic biology, microbiome research, and regenerative medicine. Experts in these fields can provide valuable foresight into which trends have the most potential for growth and disruption, helping both journalists and investors identify promising opportunities in the biotechnology sector.
To make biotech investment content stand out, publishers should focus on providing unique insights, data-driven analysis, and expert opinions. This can be achieved by collaborating with seasoned biotech investors and researchers who can offer exclusive perspectives on emerging trends, breakthrough technologies, and potential market disruptors. Additionally, publishers can differentiate their content by exploring niche areas within biotechnology, such as gene editing, personalized medicine, or bioinformatics, and explaining their investment implications in clear, accessible language.